Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons

• Published in: EBioMedicine Vol. 45; pp. 362 - 378
• Main Authors: Akiyama, Tetsuya, Suzuki, Naoki, Ishikawa, Mitsuru, Fujimori, Koki, Sone, Takefumi, Kawada, Jiro, Funayama, Ryo, Fujishima, Fumiyoshi, Mitsuzawa, Shio, Ikeda, Kensuke, Ono, Hiroya, Shijo, Tomomi, Osana, Shion, Shirota, Matsuyuki, Nakagawa, Tadashi, Kitajima, Yasuo, Nishiyama, Ayumi, Izumi, Rumiko, Morimoto, Satoru, Okada, Yohei, Kamei, Takayuki, Nishida, Mayumi, Nogami, Masahiro, Kaneda, Shohei, Ikeuchi, Yoshiho, Mitsuhashi, Hiroaki, Nakayama, Keiko, Fujii, Teruo, Warita, Hitoshi, Okano, Hideyuki, Aoki, Masashi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.07.2019; Elsevier
• Subjects: Amyotrophic lateral sclerosis (ALS); Amyotrophic Lateral Sclerosis - genetics; Amyotrophic Lateral Sclerosis - pathology; Animals; Axon branching; Axons - metabolism; Axons - pathology; Cell Differentiation - genetics; Cell Line; Fos-B; Fused in sarcoma (FUS); Gene Editing - methods; High-Throughput Nucleotide Sequencing; Human-induced pluripotent stem cell (hiPSC)-derived motor neuron; Humans; Induced Pluripotent Stem Cells - metabolism; Lentivirus - genetics; Motor Neurons - metabolism; Mutation; Nerve organoid; Neurogenesis - genetics; Phenotype; Proto-Oncogene Proteins c-fos - genetics; Research paper; RNA, Small Interfering - genetics; RNA-Binding Protein FUS - genetics; Human-induced pluripotent stem cell (hiPSC)-derived motor neuron; Fos-B; Axon branching; Amyotrophic lateral sclerosis (ALS); Nerve organoid; Fused in sarcoma (FUS)
• ISSN: 2352-3964; 2352-3964
• DOI: 10.1016/j.ebiom.2019.06.013

The characteristic structure of motor neurons (MNs), particularly of the long axons, becomes damaged in the early stages of amyotrophic lateral sclerosis (ALS). However, the molecular pathophysiology of axonal degeneration remains to be fully elucidated. Two sets of isogenic human-induced pluripotent stem cell (hiPSCs)-derived MNs possessing the single amino acid difference (p.H517D) in the fused in sarcoma (FUS) were constructed. By combining MN reporter lentivirus, MN specific phenotype was analyzed. Moreover, RNA profiling of isolated axons were conducted by applying the microfluidic devices that enable axon bundles to be produced for omics analysis. The relationship between the target gene, which was identified as a pathological candidate in ALS with RNA-sequencing, and the MN phenotype was confirmed by intervention with si-RNA or overexpression to hiPSCs-derived MNs and even in vivo. The commonality was further confirmed with other ALS-causative mutant hiPSCs-derived MNs and human pathology. We identified aberrant increasing of axon branchings in FUS-mutant hiPSCs-derived MN axons compared with isogenic controls as a novel phenotype. We identified increased level of Fos-B mRNA, the binding target of FUS, in FUS-mutant MNs. While Fos-B reduction using si-RNA or an inhibitor ameliorated the observed aberrant axon branching, Fos-B overexpression resulted in aberrant axon branching even in vivo. The commonality of those phenotypes was further confirmed with other ALS causative mutation than FUS. Analyzing the axonal fraction of hiPSC-derived MNs using microfluidic devices revealed that Fos-B is a key regulator of FUS-mutant axon branching. Japan Agency for Medical Research and development; Japanese Ministry of Education, Culture, Sports, Science and Technology Clinical Research, Innovation and Education Center, Tohoku University Hospital; Japan Intractable Diseases (Nanbyo) Research Foundation; the Kanae Foundation for the Promotion of Medical Science; and “Inochi-no-Iro” ALS research grant.